Chronic kidney disease (CKD) is a major medical and social problem associated with a high risk of cardiovascular complications, disability, and mortality. Arterial hypertension is one of the most important factors contributing to the onset and progression of CKD. Persistent elevation of blood pressure leads to renal microvascular damage, glomerular hypertension, nephrosclerosis, albuminuria, and progressive decline in glomerular filtration rate. At the same time, impaired renal function contributes to sodium and fluid retention, activation of the renin–angiotensin–aldosterone system, and further elevation of blood pressure. This creates a vicious pathogenetic circle that accelerates the progression of renal dysfunction. The aim of this article is to evaluate the role of arterial hypertension in the progression of chronic kidney disease and to analyze the clinical and functional indicators associated with an unfavorable prognosis. The review highlights the prognostic importance of blood pressure level, estimated glomerular filtration rate, albuminuria, cardiovascular comorbidity, and duration of hypertension in patients with CKD.

Chronic kidney disease, arterial hypertension, glomerular filtration rate

Karimov M.M., Daminov B.T., Kayumov U.K. Chronic kidney disease as a medico-social problem and risk factors for its development. Vestnik TMA. 2015;2.

Rasulev Y., Daminov B., Tursunbayev A. Epidemiology of chronic kidney disease in the Republic of Uzbekistan. Nephrology Dialysis Transplantation. 2023;38(Supplement 1):gfad063d_2537. DOI: 10.1093/ndt/gfad063d_2537.

Sharapov O., Daminov B. Cardiovascular Diseases in Dialysis Patients at Different Levels of Healthcare of the Republic of Uzbekistan. Central Asian Journal of Nephrology. 2025;1(1):cajn001. DOI: 10.63946/cajn/16627.

Sharapov O.N., Daminov B.T., Yarygina S.V., Dyagilev V.A. Comparative study of the structure of cardiovascular pathologies in rural and urban populations of the Republic of Uzbekistan with stage 5 chronic kidney disease on programmed hemodialysis. Clinical Nephrology. 2020;3:10–14. DOI: 10.18565/nephrology.2020.3.10-14.

Yuldashova Yu.Kh., Daminov B.T. Clinical manifestations of stage V chronic kidney disease on dialysis and features of symptomatic intradialytic hypotension. Nephrology. 2025.

Muminov Sh.K., Kosimova G.B. Pathogenesis of intradialytic hemodynamic instability. Cardiology of Uzbekistan. 2024;1(2):143–147. DOI: 10.70626/cardiouz-2024-1-00017.

Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4S):S117–S314.

Kidney Disease: Improving Global Outcomes Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International. 2021;99(3S):S1–S87.

Mancia G., Kreutz R., Brunström M., et al. 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension. 2023;41(12):1874–2071.

Chazova I.E., Zhernakova Yu.V., Kobalava Zh.D., et al. Arterial hypertension and chronic kidney disease: consensus statement on patient management. Systemic Hypertension. 2023.

World Health Organization. Hypertension. WHO Fact Sheet. 2025.

Bikbov B., Purcell C.A., Levey A.S., Smith M., Abdoli A., Abebe M., et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395(10225):709–733.

Levin A., Tonelli M., Bonventre J., Coresh J., Donner J.A., Fogo A.B., et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. The Lancet. 2017;390(10105):1888–1917. DOI: 10.1016/S0140-6736(17)30788-2.

Matsushita K., van der Velde M., Astor B.C., Woodward M., Levey A.S., de Jong P.E., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts. The Lancet. 2010;375(9731):2073–2081.

Jager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C. A single number for advocacy and communication — worldwide more than 850 million individuals have kidney diseases. Nephrology Dialysis Transplantation. 2019;34(11):1803–1805. DOI: 10.1093/ndt/gfz174